Cover Image
Shiva Abolhasani(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Seyyed Sina Hejazian(Tabriz University of Medical Sciences), Vahid Karpisheh(Tabriz University of Medical Sciences), Atefeh Khodakarami(Tabriz University of Medical Sciences), Jamshid Gholizadeh Navashenaq(Bam University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Hamed Mohammadi(Tehran University of Medical Sciences)
Cited by 0
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
|Molecular Immunology|2018|194